Temperature Dependence of Cell-cell Fusion Induced by the Envelope Glycoprotein of Human Immunodeficiency Virus Type 1
Overview
Affiliations
We investigated cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1 strain IIIB expressed on the surface of CHO cells. These cells formed syncytia when incubated together with CD4-positive human lymphoblastoid SupT1 cells or HeLa-CD4 cells but not when incubated with CD4-negative cell lines. A new assay for binding and fusion was developed by using fluorescent phospholipid analogs that were produced in SupT1 cells by metabolic incorporation of BODIPY-labeled fatty acids. Fusion occurred as early as 10 min after mixing of labeled SupT1 cells with unlabeled CHO-gp160 cells at 37 degrees C. When both the fluorescence assay and formation of syncytia were used, fusion of SupT1 and HeLa-CD4 cells with CHO-gp160 cells was observed only at temperatures above 25 degrees C, confirming recent observations (Y.-K. Fu, T.K. Hart, Z.L. Jonak, and P.J. Bugelski, J. Virol. 67:3818-3825, 1993). This temperature dependence was not observed with influenza virus-induced cell-cell fusion, which was quantitatively similar at both 20 and 37 degrees C, indicating that cell-cell fusion in general is not temperature dependent in this range. gp120-CD4-specific cell-cell binding was found over the entire 0 to 37 degrees C range but increased markedly above 25 degrees C. The enhanced binding and fusion were reduced by cytochalasins B and D. Binding of soluble gp120 to CD4-expressing cells was equivalent at 37 and 16 degrees C. Together, these data indicate that during gp120-gp41-induced syncytium formation, initial cell-cell binding is followed by a cytoskeleton-dependent increase in the number of gp120-CD4 complexes, leading to an increase in the avidity of cell-cell binding. The increased number of gp120-CD4 complexes is required for fusion, which suggests that the formation of a fusion complex consisting of multiple CD4 and gp120-gp41 molecules is a step in the fusion mechanism.
Sainova I, Kolyovska V, Ilieva I, Markova T, Dimitrova-Dikanarova D, Hadjiolova R Vaccines (Basel). 2023; 11(7).
PMID: 37515042 PMC: 10386085. DOI: 10.3390/vaccines11071226.
Chiliveri S, Louis J, Best R, Bax A J Mol Biol. 2022; 434(16):167683.
PMID: 35700771 PMC: 9378563. DOI: 10.1016/j.jmb.2022.167683.
Yuan Y, Jacobs C, Garcia I, Pereira P, Lawrence S, Laine R Viruses. 2021; 13(1).
PMID: 33478139 PMC: 7835772. DOI: 10.3390/v13010142.
Gale P Microb Risk Anal. 2020; 15:100104.
PMID: 32292808 PMC: 7110232. DOI: 10.1016/j.mran.2020.100104.
Highly integrated microfluidic device for cell pairing, fusion and culture.
He W, Huang L, Feng Y, Liang F, Ding W, Wang W Biomicrofluidics. 2020; 13(5):054109.
PMID: 31893009 PMC: 6932852. DOI: 10.1063/1.5124705.